DK2672986T3 - Frysetørrede formuleringer - Google Patents
Frysetørrede formuleringer Download PDFInfo
- Publication number
- DK2672986T3 DK2672986T3 DK12744782.9T DK12744782T DK2672986T3 DK 2672986 T3 DK2672986 T3 DK 2672986T3 DK 12744782 T DK12744782 T DK 12744782T DK 2672986 T3 DK2672986 T3 DK 2672986T3
- Authority
- DK
- Denmark
- Prior art keywords
- dried formulations
- frozen dried
- frozen
- formulations
- dried
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39591—Stabilisation, fragmentation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/02—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length in solution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/244—Interleukins [IL]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2878—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the NGF-receptor/TNF-receptor superfamily, e.g. CD27, CD30, CD40, CD95
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2887—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against CD20
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/569—Single domain, e.g. dAb, sdAb, VHH, VNAR or nanobody®
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Zoology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161440918P | 2011-02-09 | 2011-02-09 | |
| PCT/US2012/024452 WO2012109429A2 (en) | 2011-02-09 | 2012-02-09 | Lyophilized formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK2672986T3 true DK2672986T3 (da) | 2020-06-08 |
Family
ID=46639199
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK12744782.9T DK2672986T3 (da) | 2011-02-09 | 2012-02-09 | Frysetørrede formuleringer |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US10286037B2 (da) |
| EP (1) | EP2672986B1 (da) |
| JP (1) | JP6125436B2 (da) |
| KR (1) | KR20140044305A (da) |
| CN (2) | CN107837395A (da) |
| AU (1) | AU2012214419B2 (da) |
| BR (1) | BR112013020383A2 (da) |
| CA (1) | CA2827033A1 (da) |
| DK (1) | DK2672986T3 (da) |
| EA (1) | EA029972B1 (da) |
| ES (1) | ES2791690T3 (da) |
| IL (1) | IL227896B (da) |
| MX (1) | MX2013009280A (da) |
| SG (1) | SG192671A1 (da) |
| WO (1) | WO2012109429A2 (da) |
| ZA (1) | ZA201306118B (da) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009120927A2 (en) | 2008-03-28 | 2009-10-01 | Smithkline Beecham Corporation | Methods of treatment |
| EA038573B1 (ru) | 2014-03-24 | 2021-09-16 | Биовератив Терапьютикс Инк. | Лиофилизированный состав, содержащий фактор ix, для предупреждения приступов кровотечения |
| CN103920148B (zh) * | 2014-04-24 | 2016-06-22 | 山东新华医疗器械股份有限公司 | 一种单克隆抗体制剂的冷冻干燥工艺 |
| CN103966323A (zh) * | 2014-04-25 | 2014-08-06 | 广州迪澳生物科技有限公司 | 可常温运输的干粉化恒温扩增检测试剂及其制备方法 |
| WO2015171810A1 (en) * | 2014-05-06 | 2015-11-12 | The Regents Of The University Of Colorado, A Body Corporate | Compositions, methods and uses for thermally stable human papillomavirus formulations |
| US11273127B2 (en) * | 2014-05-06 | 2022-03-15 | The Regents Of The University Of Colorado, A Body Corporate | Compositions, methods and uses for thermally stable multi-targeted antigens |
| US20180021409A1 (en) * | 2014-06-25 | 2018-01-25 | Glaxosmithkline Llc | Pharmaceutical Composition |
| AR105616A1 (es) | 2015-05-07 | 2017-10-25 | Lilly Co Eli | Proteínas de fusión |
| EP3313420B1 (en) | 2015-06-25 | 2024-03-13 | The Children's Medical Center Corporation | Methods and compositions relating to hematopoietic stem cell expansion, enrichment, and maintenance |
| TWI750133B (zh) | 2015-08-24 | 2021-12-21 | 美商葛蘭素史密斯克萊有限責任公司 | 生藥組成物 |
| EP4049665A1 (en) | 2016-03-15 | 2022-08-31 | Children's Medical Center Corporation | Methods and compositions relating to hematopoietic stem cell expansion |
| CN107661288A (zh) * | 2016-07-29 | 2018-02-06 | 江苏泰康生物医药有限公司 | 含有glp‑1 类似物融合蛋白的稳定液体制剂及其制备 |
| CA3047059A1 (en) * | 2016-12-19 | 2018-06-28 | Glenmark Pharmaceuticals S.A. | Novel tnfr agonists and uses thereof |
| MX2019007433A (es) * | 2016-12-22 | 2019-08-16 | Genentech Inc | Metodos y formulaciones para reducir el tiempo de reconstitucion de los polipeptidos liofilizados. |
| EP3634467A4 (en) | 2017-06-06 | 2021-07-28 | GlaxoSmithKline LLC | BIOPHARMACEUTICAL COMPOSITIONS AND PROCEDURES FOR PEDIATRIC PATIENTS |
| CN110747263B (zh) * | 2019-11-12 | 2023-04-07 | 南京黎明生物制品有限公司 | 一种冻干添加剂及荧光pcr反应混合物干粉和制备方法 |
| CN111165656A (zh) * | 2020-01-09 | 2020-05-19 | 南京大学（溧水）生态环境研究院 | 一种黑水虻冻干粉高效制备方法 |
| CN113081955B (zh) * | 2020-01-09 | 2023-10-24 | 鲁南制药集团股份有限公司 | 一种免疫抑制剂单克隆抗体的制剂 |
| CN116643056A (zh) * | 2022-02-15 | 2023-08-25 | 厦门万泰凯瑞生物技术有限公司 | 促甲状腺激素受体复合物、试剂盒、制备方法和用途 |
| WO2023225534A1 (en) | 2022-05-18 | 2023-11-23 | Protomer Technologies Inc. | Aromatic boron-containing compounds and related insulin analogs |
| CN116159027A (zh) * | 2022-12-29 | 2023-05-26 | 江苏诺泰澳赛诺生物制药股份有限公司 | 一种司美格鲁肽冻干药物组合物及其制备方法 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9803448D0 (en) | 1998-02-18 | 1998-04-15 | Pharma Mar Sa | Pharmaceutical formulation |
| US20030017169A1 (en) * | 2000-12-29 | 2003-01-23 | Sidney Pestka | Controlled release systems for polymers |
| EP2277910A1 (en) * | 2001-12-21 | 2011-01-26 | Human Genome Sciences, Inc. | Albumin fusion proteins |
| US7582312B2 (en) * | 2004-11-15 | 2009-09-01 | Discovery Laboratories, Inc. | Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
| US8436190B2 (en) * | 2005-01-14 | 2013-05-07 | Cephalon, Inc. | Bendamustine pharmaceutical compositions |
| US8202837B2 (en) | 2005-11-04 | 2012-06-19 | Glaxosmithkline Llc | Methods for administering hypoglycemic agents |
| RU2464973C2 (ru) | 2006-01-24 | 2012-10-27 | НексБио, Инк. | Технология изготовления макромолекулярных микросфер |
| CN101558081B (zh) * | 2006-12-11 | 2014-08-20 | 伯拉考成像股份公司 | 用于诊断和治疗应用的纤维蛋白结合肽缀合体 |
| CN101274096B (zh) * | 2007-03-29 | 2011-04-27 | 上海万兴生物制药有限公司 | 一种稳定的巴曲酶药物组合物 |
| KR101478779B1 (ko) | 2007-11-22 | 2015-01-05 | 에스케이케미칼주식회사 | 재수화시간이 향상된 택산 유도체 함유 동결건조 조성물 및이의 제조방법 |
| US8275057B2 (en) * | 2008-12-19 | 2012-09-25 | Intel Corporation | Methods and systems to estimate channel frequency response in multi-carrier signals |
| WO2011017070A1 (en) | 2009-07-28 | 2011-02-10 | Merck Sharp & Dohme Corp. | Methods for producing high concentration lyophilized pharmaceutical formulations |
| CN102573459A (zh) | 2009-08-04 | 2012-07-11 | 弗·哈夫曼-拉罗切有限公司 | 粘度降低的浓缩多肽制剂 |
| CN102018676B (zh) * | 2010-12-21 | 2012-12-05 | 中山大学 | 一种水溶性药物纳米粒及其混悬型气雾剂的制备方法 |
-
2012
- 2012-02-09 EA EA201391136A patent/EA029972B1/ru not_active IP Right Cessation
- 2012-02-09 BR BR112013020383A patent/BR112013020383A2/pt not_active Application Discontinuation
- 2012-02-09 MX MX2013009280A patent/MX2013009280A/es not_active Application Discontinuation
- 2012-02-09 SG SG2013060181A patent/SG192671A1/en unknown
- 2012-02-09 JP JP2013553559A patent/JP6125436B2/ja active Active
- 2012-02-09 CN CN201711059310.0A patent/CN107837395A/zh active Pending
- 2012-02-09 US US13/984,536 patent/US10286037B2/en active Active
- 2012-02-09 WO PCT/US2012/024452 patent/WO2012109429A2/en active Application Filing
- 2012-02-09 CA CA2827033A patent/CA2827033A1/en not_active Abandoned
- 2012-02-09 AU AU2012214419A patent/AU2012214419B2/en not_active Ceased
- 2012-02-09 DK DK12744782.9T patent/DK2672986T3/da active
- 2012-02-09 KR KR1020137023408A patent/KR20140044305A/ko active IP Right Grant
- 2012-02-09 EP EP12744782.9A patent/EP2672986B1/en active Active
- 2012-02-09 ES ES12744782T patent/ES2791690T3/es active Active
- 2012-02-09 CN CN201280017617.3A patent/CN103492407A/zh active Pending
-
2013
- 2013-08-08 IL IL227896A patent/IL227896B/en active IP Right Grant
- 2013-08-14 ZA ZA2013/06118A patent/ZA201306118B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN107837395A (zh) | 2018-03-27 |
| JP6125436B2 (ja) | 2017-05-10 |
| EP2672986A2 (en) | 2013-12-18 |
| EA029972B1 (ru) | 2018-06-29 |
| EP2672986A4 (en) | 2015-12-30 |
| EP2672986B1 (en) | 2020-03-18 |
| CN103492407A (zh) | 2014-01-01 |
| IL227896B (en) | 2018-12-31 |
| EA201391136A1 (ru) | 2014-05-30 |
| BR112013020383A2 (pt) | 2017-06-13 |
| KR20140044305A (ko) | 2014-04-14 |
| SG192671A1 (en) | 2013-09-30 |
| AU2012214419B2 (en) | 2015-12-24 |
| IL227896A0 (en) | 2013-09-30 |
| WO2012109429A2 (en) | 2012-08-16 |
| CA2827033A1 (en) | 2012-08-16 |
| US20140044717A1 (en) | 2014-02-13 |
| JP2014506578A (ja) | 2014-03-17 |
| AU2012214419A1 (en) | 2013-08-29 |
| MX2013009280A (es) | 2013-09-06 |
| ES2791690T3 (es) | 2020-11-05 |
| ZA201306118B (en) | 2014-04-30 |
| US10286037B2 (en) | 2019-05-14 |
| WO2012109429A3 (en) | 2012-10-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK2672986T3 (da) | Frysetørrede formuleringer | |
| BR112013033332A2 (pt) | calçado | |
| BR112014000015A2 (pt) | formulação | |
| UA23340S (uk) | Цукерка | |
| UA21334S (uk) | Цукерка | |
| BR112014005511A2 (pt) | túnel | |
| DOS2010000249S (es) | Confiteria | |
| BR112014007790A2 (pt) | derivado de fenila | |
| BR112014000533A2 (pt) | composição comestível | |
| DK2672817T3 (da) | Forbedrede insekticide formuleringer | |
| DE112012001027A5 (de) | Hochfrequenz-Leistungsvervielfacherlösung | |
| CR20140186A (es) | Composiciones mejoradas | |
| AT12022U3 (de) | Wäschetrockneranordnung | |
| FR2980843B1 (fr) | Projectile gyrostabilise | |
| AT12225U2 (de) | Schubwendetrockner | |
| DE112011101266A5 (de) | Kühlregal | |
| FI10522U1 (fi) | Sihti | |
| FR2967069B3 (fr) | Formulations | |
| DK2598472T3 (da) | Formuleringer | |
| FI20115875A0 (fi) | Kuivuri | |
| FI20110060A0 (fi) | Vaivaton jääkenkä | |
| UA24551S (uk) | Морозиво | |
| DK2508059T3 (da) | Spreder | |
| FIU20100345U0 (fi) | Kuivain | |
| FI20110198A0 (fi) | Pelinappula |